3 Top Generic Drug Stocks to Consider Buying Now
Brand-name drugs tend to capture all the headlines, but did you know that nine out of every 10 prescriptions filled in the U.S. each year are generic? When added together, Americans spend spent about $116 billion on generic drugs in 2016, according to Statista. The numbers get much larger when you zoom to include the rest of the world.
Given the size of the market, it should come as no surprise to see that scores of pharma companies want a piece of the action. Here's a list of 10 publicly traded companies that are major competitors in the generic drug space.
Table Source: Yahoo! Finance
Source: Fool.com
Pfizer Inc. Stock
€25.87
-0.250%
The stock is one of the favorites of our community with 35 Buy predictions and 4 Sell predictions.
As a result the target price of 40 € shows a very positive potential of 54.62% compared to the current price of 25.87 € for Pfizer Inc..
